Skip to main content
Article thumbnail
Location of Repository

Amyloidogenesis Abolished by Proline Substitutions but Enhanced by Lipid Binding

By Ping Jiang, Weixin Xu and Yuguang Mu


The influence of lipid molecules on the aggregation of a highly amyloidogenic segment of human islet amyloid polypeptide, hIAPP20–29, and the corresponding sequence from rat has been studied by all-atom replica exchange molecular dynamics (REMD) simulations with explicit solvent model. hIAPP20–29 fragments aggregate into partially ordered β-sheet oligomers and then undergo large conformational reorganization and convert into parallel/antiparallel β-sheet oligomers in mixed in-register and out-of-register patterns. The hydrophobic interaction between lipid tails and residues at positions 23–25 is found to stabilize the ordered β-sheet structure, indicating a catalysis role of lipid molecules in hIAPP20–29 self-assembly. The rat IAPP variants with three proline residues maintain unstructured micelle-like oligomers, which is consistent with non-amyloidogenic behavior observed in experimental studies. Our study provides the atomic resolution descriptions of the catalytic function of lipid molecules on the aggregation of IAPP peptides

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2003). alpha-Synuclein oligomerization: a role for lipids? Trends in
  2. (2006). AMBER 9. San Francisco:
  3. (2008). Amyloid Fiber Formation and Membrane Disruption are Separate Processes Localized in Two Distinct Regions of IAPP, the Type-2-Diabetes-Related Peptide.
  4. (1988). Amyloid Fibrils Formed from a Segment of the Pancreatic-Islet Amyloid Protein.
  5. (2005). Amyloid ion channels: A common structural link for protein-misfolding disease.
  6. (2008). Atomic structure of the cross-{beta} spine of islet amyloid polypeptide (amylin).
  7. (2008). Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin).
  8. (2004). Caflisch A
  9. (2008). Calcium-activated membrane interaction of the islet amyloid polypeptide: Implications in the pathogenesis of type II diabetes mellitus.
  10. (2006). Characteristics of Fibers Formed by Cytochrome c and Induced by Anionic Phospholipids.
  11. (1989). Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets.
  12. (2000). Conformational disease.
  13. (2003). Conformational preferences of the amylin nucleation site in SDS micelles: An NMR study.
  14. (1998). Conformational studies of human islet amyloid peptide using molecular dynamics and simulated annealing methods.
  15. (1989). Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone.
  16. (2002). Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis.
  17. (1996). Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids.
  18. (1983). Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features.
  19. (2003). Dissecting the Assembly of A[beta]16–22 Amyloid Peptides into Antiparallel [beta]
  20. (2005). Energy landscape of a small peptide revealed by dihedral angle principal component analysis.
  21. (2001). Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides.
  22. (2004). Exploring protein native states and large-scale conformational changes with a modified generalized born model.
  23. (2008). Formation and Growth of Oligomers: A Monte Carlo Study of an Amyloid Tau Fragment.
  24. (2004). Formation of Amyloid Fibers Triggered by Phosphatidylserine-Containing Membranes.
  25. (2004). Formation of partially ordered oligomers of amyloidogenic hexapeptide (NFGAIL) in aqueous solution observed in molecular dynamics simulations.
  26. (2001). GROMACS 3.0: a package for molecular simulation and trajectory analysis.
  27. (2005). GROMACS: Fast, flexible, and free.
  28. (2007). Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets.
  29. (2007). Hydrophobic Cooperativity as a Mechanism for Amyloid Nucleation.
  30. (2004). In silico assembly of Alzheimer’s Abeta16–22 peptide into beta-sheets.
  31. (2004). In silico study of amyloid I ˆ2-protein folding and oligomerization.
  32. (2004). Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions.
  33. (1982). Insular amyloidosis in spontaneously diabetic nonhuman primates.
  34. (2008). Interaction of membranebound islet amyloid polypeptide with soluble and crystalline insulin.
  35. (2005). Intersheet rearrangement of polypeptides during nucleation of beta-sheet aggregates.
  36. (2000). Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson’s disease? Nature Cell Biology 2: E115–119. Lipid Molecule Enhances Aggregation of hIAPP PLoS
  37. (2000). Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP.
  38. (1990). Islet Amyloid Polypeptide - Pinpointing Amino-Acid-Residues Linked to Amyloid Fibril Formation.
  39. (2008). Islet Amyloid Polypeptide Forms Rigid Lipid-Protein Amyloid Fibrils on Supported Phospholipid Bilayers.
  40. (1973). Light and electron microscopic studies of islet amyloid in diabetic cats.
  41. (1997). LINCS: A linear constraint solver for molecular simulations.
  42. (1989). Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects.
  43. (2007). Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy.
  44. (2008). Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.
  45. (2007). Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process.
  46. (2008). Models of Toxic Beta-Sheet Channels of Protegrin-1 Suggest a Common Subunit Organization Motif Shared with Toxic Alzheimer Beta-Amyloid Ion Channels.
  47. (2002). Molecular dynamics simulations of alanine rich {beta}-sheet oligomers: Insight into amyloid formation.
  48. (2004). Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides.
  49. (2007). Monomer adds to preformed structured oligomers of Abeta-peptides by a two-stage dock-lock mechanism.
  50. (2002). Naturally secreted oligomers of amyloid [beta] protein potently inhibit hippocampal longterm potentiation in vivo.
  51. (2002). Neurodegenerative disease: Amyloid pores from pathogenic mutations.
  52. (2000). Nucleated Conformational Conversion and the Replication of Conformational Information by a Prion Determinant.
  53. (1996). On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants.
  54. (1993). Particle mesh Ewald: An NNlog(N) method for Ewald sums in large systems.
  55. (2007). Peptide Conformation and Supramolecular Organization in Amylin Fibrils: Constraints from Solid-State NMR.
  56. (2004). Phospholipid catalysis of diabetic amyloid assembly.
  57. (1998). Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometry.
  58. (2008). Protein misfolding and disease:
  59. (2005). Raft lipids as common components of human extracellular amyloid fibrils.
  60. (2004). Ramamoorthy A
  61. (2004). Rapid Photochemical Cross-Linking A New Tool for Studies of Metastable, Amyloidogenic Protein Assemblies.
  62. (1989). Rat amylin: cloning and tissue-specific expression in pancreatic islets.
  63. (1999). Replica-exchange molecular dynamics method for protein folding.
  64. (1995). Rotational Resonance Solid-State NMR Elucidates a Structural Model of Pancreatic Amyloid.
  65. (2006). Secondary structure provides a template for the folding of nearby polypeptides.
  66. (1989). Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species.
  67. (2008). Structural Insights into the Polymorphism of Amyloid-Like Fibrils Formed by Region 20– 29 of Amylin Revealed by Solid-State NMR and X-ray Fiber Diffraction.
  68. (2007). Structural Reorganisation and Potential Toxicity of Oligomeric Species Formed during the Assembly of Amyloid Fibrils.
  69. (1995). Structural Studies on Fap Fibrils - Removal of Contaminants Is Essential for the Interpretation of X-Ray Data.
  70. (2008). Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding.
  71. (2004). Techniques to study amyloid fibril formation in vitro.
  72. (2003). The Formation of Highly Soluble Oligomers of ? Synuclein Is Regulated by Fatty Acids and Enhanced
  73. (1967). The lipid content of amyloid fibrils purified by a variety of methods.
  74. (1988). The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin.
  75. (2006). The Organization of Aromatic Side Groups in an Amyloid Fibril Probed by SolidState 2H and 19F NMR Spectroscopy.
  76. (1996). VMD: visual molecular dynamics.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.